-
- Sales of medical devices for elective procedures like spine and knee surgery lagged behind other medical device segments, which the company partially attributed to procedural backlogs.
-
- Johnson & Johnson’s U.S. orthopedics sales declined 4.5 percent compared to the same period in 2020.
-
- Hip device sales grew 2.3 percent globally compared to last year, while knee devices grew 2 percent.
-
- After introducing 17 medical devices in the first half of 2021, Johnson & Johnson introduced the Inhance Shoulder System in Q3 on Aug. 13.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
